Cabozantinib with nivolumab
- Status:
- Red
- Decision Date:
- April 2024
Comments
SSC2626: for untreated advanced renal cell carcinoma. NHSE commissioned.
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again
